Low dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats

This publication has 60 references indexed in Scilit:

• Effects of alpha-linolenic acid vs. docosahexaenoic acid supply on the distribution of fatty acids among the rat cardiac subcellular membranes after a short- or long-term dietary exposure
  Nutrition & Metabolism, 2009
• Omega-6 Fatty Acids and Risk for Cardiovascular Disease
  Circulation, 2009
• Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction
  Cardiovascular Research, 2008
• Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
  The Lancet, 2008
• Effects of Omega-3 Fatty Acids on Heart Rate in Cardiac Transplant Recipients††Disclaimer: Saint Luke’s Hospital holds a minority interest in OmegaMetrix, LLC, Kansas City, Missouri, a company offering blood omega-3 fatty acid testing.
  The American Journal of Cardiology, 2006
• Fish Intake, Contaminants, and Human Health
  JAMA, 2006
• Dietary Omega-3 Fatty Acid Intake and Cardiovascular Risk
  The American Journal of Cardiology, 2006
• Fish and Long-Chain ω-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women
  Circulation, 2003
• Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion
  American Heart Journal, 1988
• The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
  New England Journal of Medicine, 1985